fashion -WSS

fashion

author：fashion 2025-09-30 19:25:16 - browse：8

A few years ago, Vijay Pande, then a professor at Stanford who was using computer science to understand biology, was deciding whether to leave full-time academic work to become a venture capitalist. He turned to Andrew Ng, another Stanford professor who had joined Google Brain and later the Chinese search firm Baidu.

“The things that we dreamed about five or 10 years ago were happening now,” Pande recalled Ng telling him. “The question was, do you want to be a part of it? Or do you want to write another paper?”

Pande decided to become a venture capitalist. The result, he told an audience at a STAT event in San Francisco last week, is that, whereas he managed about $1 million to $2 million in research as a top academic, he now works at the fabled Silicon Valley firm Andreessen Horowitz, which invests $100 million a year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： How dance can help nurses traumatized by Covid

WSS

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

AI can’t replace a physician’s gut feeling

A public scorecard can help hold safety

First Opinion Podcast: How to protect health care in times of war

Readout Newsletter: XBI biotech index, Akero Therapeutics

Emergency medicine has repudiated 'excited delirium.' Now what?

Wikipedia

fashion

leisure time

At least 13 dead in Texas as scorching temps continue

Startup Neumora takes a novel depression drug to Phase 3

Duchenne breakthrough therapy leaves behind pioneering families

Chimpanzees, like humans and whales, get menopause: Study

The high cost of giving birth even with insurance

A public scorecard can help hold safety

As demand for Covid shots wanes, Moderna seeks its next success

How dance can help nurses traumatized by Covid

Drug repurposing or repositioning? The language matters

Cassava reveals details — and problems — with Alzheimer's study

knowledge

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Biden's order seeks to regulate AI risk without stifling innovation

The FDA weighs the risks of candy

Cosmetics set for new safety regulation. Why the industry is on board

Senate panel to vote on hospitals, PBMs, prisoner care

Group opposing PBM reform sets lobbying record

hotspot

knowledge

knowledge

hotspot